Abstract
Aims
In countries with social healthcare systems, such as Canada, patients may experience long wait times and a decline in their health status prior to their operation. The aim of this study is to explore the association between long preoperative wait times (WT) and acute hospital length of stay (LoS) for primary arthroplasty of the knee and hip.
Methods
The study population was obtained from the provincial Patient Access Registry Nova Scotia (PARNS) and the Canadian national hospital Discharge Access Database (DAD). We included primary total knee and hip arthroplasties (TKA, THA) between 2011 and 2017. Patients waiting longer than the recommended 180 days Canadian national standard were compared to patients waiting equal or less than the standard WT. The primary outcome measure was acute LoS postoperatively. Secondarily, patient demographics, comorbidities, and perioperative parameters were correlated with LoS with multivariate regression.
Results
A total of 11,833 TKAs and 6,627 THAs were included in the study. Mean WT for TKA was 348 days (1 to 3,605) with mean LoS of 3.6 days (1 to 98). Mean WT for THA was 267 days (1 to 2,015) with mean LoS of 4.0 days (1 to 143). There was a significant increase in mean LoS for TKA waiting longer than 180 days (2.5% (SE 1.1); p = 0.028). There was no significant association for THA. Age, sex, surgical year, admittance from home, rural residence, household income, hospital facility, the need for blood transfusion, and comorbidities were all found to influence LoS.
Conclusion
Surgical WT longer than 180 days resulted in increased acute LoS for primary TKA. Meeting a shorter WT target may be cost-saving in a social healthcare system by having shorter LoS.
Cite this article: Bone Jt Open 2021;2(8):679–684.
Take home message
Patients waiting longer than 180 days for total knee arthroplasty have statistically longer acute care length of stay, albeit with less clinical significance.
Introduction
Total knee (TKAs) and hip arthroplasties (THAs) are immensely successful surgical procedures1 that are rationed through wait times in social health care systems such as Canada’s.2,3 Currently the benchmark for receiving arthroplasty in Canada, from decision to operate to time of operation, is set at 180 days as a national standard.4,5 Despite inflow of healthcare resources, there are unmet demands from a greying Canadian population; in 2018 only 75% of Canadians reached the recommended benchmark for THA and 69% for TKA.6 Wait times (WT) are a growing concern for patients and healthcare providers alike. Patients identify WT as unacceptably long and contributory to further deterioration of their health while waiting for surgery.7-10 Surgery performed later in the natural history of disease is shown to have significant impact on pain, function, and health-related quality of life at the time of surgery.11-14 Prospective studies have linked preoperative functional limitations to worse postoperative patient-reported outcomes.15-18
In a social healthcare system, reductions in hospital length of stay (LoS) can improve patient flow, allow for higher turnover of surgical cases, and reduce WT. LoS has been linked to numerous factors including age, sex, comorbidities, intraoperative blood loss, postoperative blood transfusion, as well as marital and socioeconomic status.19-35 Location of residence, facility of practice, surgeon and hospital volume, anaesthesia type, and preoperative patient education have also been implicated in LoS.36-43 Interestingly, prudent reduction in LoS has not been associated with an increase in the rate of readmission.44
Despite a wealthy body of literature, no study has yet directly examined the association between preoperative WT and acute inpatient hospital LoS. This study aims to examine the relation between the disproportionately large preoperative TKA and THA WT and resultant acute LoS. We hypothesize that increased preoperative wait would be associated with increased LoS. Our secondary aim is to describe risk factors associated with variations in LoS.
Methods
Study population
The study population was obtained by selecting primary TKA and THA procedures from provincial and national hospital databases and merging patient observations together based on unique identifiers from year 2011 to 2017. Databases used include Patient Access Registry Nova Scotia (PARNS), the Canadian inpatient hospital Discharge Access Database (DAD), and National Ambulatory Care Reporting System (NACRS). WT was calculated from PARNS data. LoS as well as patient demographic details and comorbidities for the two-year period prior to surgery were accessed from DAD and NACRS data. A total of 21,329 patient observations were identified between January 2011 and December 2017. Bilateral arthroplasty cases were included and comprised less than 1% of all observations. Only one patient observation had both TKA and THA procedures during the same admission. Observations were excluded based on missing linkage between PARNS and DAD/NACRS, and missing or negative values for WT or LoS. Patients with revision or emergency status were excluded. After exclusions, 18,460 observations were used in the final analytic database (Table I).
Table I.
Variable | TKA | THA |
---|---|---|
Total, n | 11,833 | 6,627 |
Mean WT, days (range) | 348 (1 to 3,605) | 267 (1 to 2,015) |
Mean LoS, days (range) | 3.6 (1 to 98) | 4.0 (1 to 143) |
Mean age, yrs (range) | 66.6 (17 to 98) | 66.0 (13 to 99) |
Female, n (%) | 59.1 | 55.0 |
Admit from home, n (%) | 99.3 | 98.3 |
Rural residence, n (%) | 35.9 | 35.2 |
Mean MHI1 per thousand CAD (range) | 63.9 (17.3 to 215) | 65.5 (17.3 to 215) |
Hospital facility, % | ||
A | 13.1 | 14.3 |
B | 19.4 | 16.6 |
C | 12.9 | 7.6 |
D | 22.2 | 17.8 |
E | 32.4 | 43.7 |
Anaesthesia, % | ||
Spinal | 29.1 | 28.7 |
Block | 6.7 | 0.6 |
Local | 1.5 | 0.42 |
Blood transfusion | 3.3 | 6.1 |
Comorbidities, % | ||
HTN | 17.9 | 15.4 |
DM | 19.1 | 12.5 |
CHF | 0.49 | 0.32 |
IHD | 2.5 | 2.5 |
PVD | 0.26 | 0.35 |
CVD | 0.32 | 0.47 |
Dementia | 0.08 | 0.35 |
CPD | 2.2 | 1.9 |
PUD | 0.15 | 0.08 |
CRF | 0.36 | 0.72 |
Hepatic disease | 0.12 | 0.08 |
Anaemia | 2.0 | 3.8 |
RA | 1.3 | 0.78 |
Cancer | 0.77 | 1.1 |
Metastatic disease | 0.14 | 0.32 |
-
CHF, congestive heart failure; CPD, chronic pulmonary disease; CRF, chronic renal failure; CVD, cerebrovascular disease; DM, diabetes mellitus; HTN, hypertension; IHD, ischemic heart disease; MHI, mean household income (units per $1000 Canadian Dollars); PUD, peptic ulcer disease and upper gastrointestinal bleed; PVD, peripheral vascular disease; RA, rheumatoid arthritis; THA, total hip arhtroplasty; TKA, total knee arthroplasty.
Statistical analysis
WT in days was calculated as the number of days between the decision to treat date and the date of surgery. The key analysis variable was a binary indicator of WT set at 180 days as per Canadian national standard. Associations between WT, risk factors, and LoS were measured with multivariate regression analysis. Variables included in the model were age, sex, rural patient residence, neighborhood median income, admission from home, hospital, anaesthesia type, admission type, and comorbidities. All variables were used to control for primary and secondary outcomes. Multivariate log-linear Poisson regression model was used to account for right skew in the LoS distribution. TKA and THA cohorts were analyzed separately. Chi-squared statistics was used to test for statistical significance at a 95% confidence level and threshold set at p < 0.05 for significance. All analyses were carried out using SAS 9.4 (SAS Institute, USA). Research ethics was granted by Nova Scotia Health Authority Research Ethics Board.
Results
Primary TKA
There were 11,833 patients in the TKA cohort with mean age of 67 years (17 to 98) and 59% female. Mean WT for primary TKA was 348 days (1 to 3,605). The patient WT distribution had a long right skew arm; the 95th percentile waited 848 days. The annual WT had increased from 333 days in 2011 to 345 days in 2017 (Figure 1a). Mean LoS for TKA was 3.6 days (1 to 98). The annual TKA LoS demonstrated a steady decline from 4.5 days in 2011 to three days in 2017.
Fig. 1
With respect to our primary outcome, LoS for patients waiting more than the 180-day benchmark was compared to patients waiting less, while controlling for all patient and perioperative parameters presented in Table I. Patients waiting longer than 180 days for primary TKA had 2.5% longer LoS (SE 1.1%; p = 0.028, Wald chi-squared test) compared to patients waiting less (Table II). This percentage value is in reference to the mean LoS (3.6 days) and represents 2.2 hours increased LoS for a single patient.
Table II.
Variable | TKA | THA | ||||
---|---|---|---|---|---|---|
IRR, % | SE | p-value | IRR, % | SE | p-value | |
WT > days | 2.5 | 1.1 | 0.028 | 1.3 | 1.3 | 0.317 |
Age (per year) | 0.9 | 0.06 | < 0.001 | 1.5 | 0.06 | < 0.001 |
Female | 8.7 | 1.0 | < 0.001 | 10.6 | 1.3 | < 0.001 |
Year of surgery (per year) | -3.8 | 0.3 | < 0.001 | -4.0 | 0.4 | < 0.001 |
Admit from home | -44.7 | 3.9 | < 0.001 | -33.4 | 3.5 | < 0.001 |
Rural residence | -5.5 | 1.2 | < 0.001 | -8.1 | 1.5 | < 0.001 |
MHI* (per thousand CAD) | -0.09 | 0.02 | < 0.001 | -0.06 | 0.03 | 0.029 |
Hospital facility † | ||||||
A | -20.4 | 2.3 | < 0.001 | -24.5 | 2.6 | < 0.001 |
B | -24.6 | 2.2 | < 0.001 | -28.9 | 2.6 | < 0.001 |
C | -24.8 | 2.0 | < 0.001 | -10.7 | 2.6 | < 0.001 |
D | -13.9 | 1.6 | < 0.001 | -12.7 | 2.0 | < 0.001 |
Anaesthesia | ||||||
Spinal | -1.0 | 1.4 | 0.479 | -1.7 | 1.6 | 0.299 |
Block | 0.2 | 2.2 | 0.914 | 10.7 | 7.5 | 0.159 |
Local | -13.4 | 5.0 | 0.003 | -6.9 | 10.2 | 0.466 |
Blood transfusion | 58.4 | 2.4 | < 0.001 | 47.5 | 2.5 | < 0.001 |
Comorbidities | ||||||
HTN | 1.8 | 1.4 | 0.193 | 14.7 | 1.8 | < 0.001 |
DM | 6.3 | 1.2 | < 0.001 | 16.6 | 1.8 | < 0.001 |
CHF | 53.2 | 4.7 | < 0.001 | 56.3 | 7.2 | < 0.001 |
IHD | 10.8 | 2.9 | < 0.001 | -4.9 | 3.7 | 0.170 |
PVD | -9.5 | 10.1 | 0.296 | 7.4 | 9.2 | 0.422 |
CVD | 56.9 | 6.9 | < 0.001 | 3.6 | 7.8 | 0.637 |
Dementia | 192.4 | 11.5 | < 0.001 | 166.5 | 5.4 | < 0.001 |
CPD | 19.1 | 3.0 | < 0.001 | 20.3 | 4.3 | < 0.001 |
PUD | 73.2 | 8.5 | < 0.001 | 354.9 | 8.2 | < 0.001 |
CRF | 28.2 | 6.4 | < 0.001 | 42.4 | 4.8 | < 0.001 |
Hepatic disease | 14.4 | 13.3 | 0.280 | 9.8 | 25.1 | 0.677 |
Anaemia | 15.4 | 3.1 | < 0.001 | 23.3 | 3.0 | < 0.001 |
RA | 3.3 | 4.6 | 0.417 | -5.7 | 7.5 | 0.419 |
Cancer | 25.5 | 5.4 | < 0.001 | 14.7 | 5.8 | 0.014 |
Metastatic disease | -10.1 | 13.9 | 0.416 | 16.1 | 9.0 | 0.083 |
-
*
IRR for MHI is per $1,000 Canadian Dollars.
-
†
Reference is academic hospital facility E.
-
CHF, congestive heart failure; CPD, chronic pulmonary disease; CRF, chronic renal failure; CVD, cerebrovascular disease; DM, diabetes mellitus; HTN, hypertension; IHD, ischemic heart disease; IRR, incidence rate ratio; MHI, mean household income; PUD, peptic ulcer disease and upper gastrointenstinal bleed; PVD, peripheral vascular disease; RA, rheumatoid arthritis; SE, standard error; THA, total hip arthroplasty; TKA, total knee arthroplasty; WT, wait time.
For our secondary outcome, patient characteristics associated with longer LoS were identified with multivariate regression analysis. The relative contribution of each characteristic is presented as percentage incidence rate ratio (IRR) and standard error (SE) in Table II. For each year of age, the mean LoS increased by 0.9% annually (SE 0.06%; p < 0.001). Female sex had 8.7% (SE 1.0%; p < 0.001) longer LoS. Receiving blood transfusions were associated with a significantly longer LoS (58.4% (SE 1.3); p < 0.001). With few exceptions, most comorbidities studied had longer LoS (Table II).
Patient characteristics associated with shorter LoS are denoted with negative IRR values in Table II. Operations performed more recently had a shorter mean LoS per surgical year (-3.8 (SE 0.3); p < 0.001). Patients who received local anaesthetic had 13.4% (SE 5.0; p = 0.003) shorter LoS. Peripheral hospitals labelled facility A to D were compared to the central academic hospital labelled facility E. Patients receiving their operations in peripheral hospitals had 13.9% to 24.8% (p < 0.001) shorter LoS. Admittance from home, rural residence, and higher mean household income were all associated with shorter LoS.
Primary THA
The THA cohort had 6,627 patients with mean age of 66 years (13 to 99) and 55% (3,645) female. THA WT distribution had a shorter mean WT of 267 days (1 to 2,015) and 95th percentile waited 742 days. The annual THA WT had increased from 247 days in 2011 to 299 days in 2017 (Figure 1b). Mean THA LoS was four days (1 to 143) and the annual THA LoS had decreased from 4.9 days in 2011 to 3.3 days in 2017. In the THA cohort, there was no significant difference in LoS for patients waiting longer than 180 days (1.3% (SE 1.3); p = 0.317, Wald chi-squared test).
Association of patient demographics and perioperative parameters followed a similar pattern to the TKA cohort with few exceptions. In the THA cohort use of local anaesthetic was not associated with shorter LoS (-6.9% (SE 10.2); p = 0.466, Wald chi-squared test). Several comorbidities differed in correlation significance compared to TKA.
Discussion
To our knowledge, this is the first study directly examining the relationship between long WT and hospital LoS for primary TKA and THA. Our WT distributions had a broad range with patients waiting years before their elective surgery. We included all the long waiters in our final analysis. Patients waiting longer than the 180-day national benchmark to receive TKA experienced a statistically significantly longer LoS. The 2.5% increase in LoS represented a small standard effect size of 2.2 hours for a single patient. Therefore, the average waiting patient can rest assured that the absolute magnitude of their hospital LoS is not drastically affected by their longer WT. However from a public health perspective, the observed 2.5% higher LoS is equivalent to 153 days of hospital bed overuse annually in our study. Providing patients with timely TKA can liberate hospital resources for more efficient use, and in our healthcare setting would allow a maximum of 42 additional TKAs to be performed annually owing to bed availability. At the individual patient level, longer LoS does not seem clinically relevant, however at the population level it may represent a cost saving target for future policies and interventions.
WT longer than 180 days for THA was not associated with longer LoS in our study despite similar patient demographic data and controlled parameters to TKA cohort. We speculate the local pattern of practice may be responsible for this discrepancy. Patients with concurrent hip and knee osteoarthritis with comparable levels of pain and disability from both joints are usually scheduled for a THA procedure first; aTKA procedure may be delayed until after initial patient recovery. Therefore, deleterious effects of waiting and deconditioning may have been less extensive in THA cohort and consequently resulted in no appreciable effect on postoperative LoS. Alternatively, it may be that the anatomy and biomechanics of the arthritic knee are less tolerant to longer WT and result in slower postoperative recovery.
We have identified several demographic and health characteristics associated with longer LoS. Age and female sex are well established risk factors for longer LoS,19-21,24-26 and their association was confirmed again. Likewise, we found that pre-existing anaemia and requirement for postoperative blood transfusion were linked to longer LoS, and they have been reported so in literature.27-29,45 Interestingly, regional blocks did not affect LoS in either the TKA or THA groups, however administration of local anaesthetic in the TKA cohort significantly reduced LoS (p = 0.003). A prior systematic review had identified local anaesthesia as an effective means for acute pain management and reduction of LoS,46 however did not demonstrate clear benefits as an adjunct to regional blocks. Many previous publications have reported on increased LoS based on composite scores such as the Charlson Comorbidity Index, American Society of Anesthesiologists (ASA) grade,47 or number of comorbidities.20,23,24,30-34 Few authors have studied separate comorbidities in the same patient population in order to compare their relative contribution to LoS. Our study is able to provide the relative significance of each comorbidity towards increased LoS and provide a basis for their comparison. Seeing our results confirming previously identified risk factors in increased LoS affirms the external validity of our findings. We can be more confident that our results can be generalized to the greater Canadian population and other social healthcare systems.
Several limitations to our study have been considered. Firstly, other confounders outside of the variables already identified may contribute to the significance of increased LoS in the TKA cohort. In fact, the deterioration in patient health while waiting can only be hypothesized, but not proven, by our methodology. Secondly, use of administrative data is prone to information misclassification and reporting biases, particularly with regards to comorbidities. Comorbidities are extracted from hospital DAD for patient admissions from two years prior to their primary arthroplasty; diagnosis of comorbidities is based on clinician reporting and lacks a pre-specified diagnostic threshold or standard diagnostic test. As such, bias may arise from our inability to verify each patient comorbidity against a pre-specified reference. Furthermore, if a patient did not have a hospital admission in the two years prior to their operation, their comorbidities would not be included in our analysis. Additionally, removal of incomplete records from the dataset based on missing linkages and missing values may introduce selection bias. Perioperative care has evolved over the studied years including perioperative patient education, postoperative patient analgesia, rehabilitation protocol, and discharge criteria. Some of the aforementioned factors account for the decreasing trends in LoS, however they are not captured within our data and may bias our findings.
In conclusion, patients waiting more than 180 days for TKA have longer acute care LoS. Longer LoS may be due to deteriorating health status while placed on a surgical waitlist and may represent an indirect cost to the patient and the healthcare system. Optimization of modifiable risk factors during the waiting period may lead to reduced LoS and reduced WT downstream. Furthermore, the identified risk factors may play a role in managing patient expectation regarding LoS during surgical consent.
References
1. Ethgen O , Bruyère O , Richy F , Dardennes C , Reginster J-. Y . Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature . J Bone Joint Surg Am . 2004 ; 86-A ( 5 ): 963 – 974 . Crossref PubMed Google Scholar
2. Hicks LL . Making hard choices. Rationing health care services . J Leg Med . 2011 ; 32 ( 1 ): 27 – 50 . Crossref PubMed Google Scholar
3. MacKinnon JC . Wait times in Canada . Healthc Manage Forum . 2017 ; 30 ( 4 ): 190 – 192 . Crossref PubMed Google Scholar
4. Masri BA , Cochrane N , Dunbar M , Duncan CP , Hughes K , Kpec J . Priority criteria for hip and knee replacement: Addressing health service wait times . 2005 . http://www.plexia.ca/masri/Waiting%20Report%20I%20July%2021_Final_.pdf ( date last accessed 25 June 2021 ). Google Scholar
5. Noseworthy T , SanMartin C , Conner-Spady B , Bohm E , DeCoster C , Dunbar M . Report 2: Towards Establishing Evidence-Based Benchmarks for Acceptable Waiting Times for Joint Replacement Surgery . Calgary : University of Calgary . 2005 . Google Scholar
6. No authors listed . Joint Replacement Wait Times . Canadian Institute for Health Information . https://yourhealthsystem.cihi.ca/hsp/inbrief#!/indicators/004/joint-replacement-wait-times/;mapC1;mapLevel2;overview ( date last accessed 19 July 2021 ). Google Scholar
7. Coyte PC , Wright JG , Hawker GA , Bombardier C , Dittus RS , Paul JE . Waiting times for knee-replacement surgery in the United States and Ontario . N Engl J Med . 1994 ; 331 ( 16 ): 1068 – 1071 . Crossref PubMed Google Scholar
8. Snider MG , MacDonald SJ , Pototschnik R . Waiting times and patient perspectives for total hip and knee arthroplasty in rural and urban Ontario . Can J Surg J Can Chir . 2005 ; 48 ( 5 ): 355 – 360 . PubMed Google Scholar
9. McHugh GA , Luker KA , Campbell M , Kay PR , Silman AJ . Pain, physical functioning and quality of life of individuals awaiting total joint replacement: a longitudinal study . J Eval Clin Pract . 2008 ; 14 ( 1 ): 19 – 26 . Crossref PubMed Google Scholar
10. Ackerman IN , Bennell KL , Osborne RH . Decline in health-related quality of life reported by more than half of those waiting for joint replacement surgery: A prospective cohort study . BMC Musculoskelet Disord . 2011 ; 12 : 108 . Crossref PubMed Google Scholar
11. Desmeules F , Dionne CE , Belzile E , Bourbonnais R , Frémont P . The burden of wait for knee replacement surgery: effects on pain, function and health-related quality of life at the time of surgery . Rheumatol Oxf Engl . 2010 ; 49 ( 5 ): 945 – 954 . Crossref PubMed Google Scholar
12. Kili S , Wright I , Jones RS . Change in Harris hip score in patients on the waiting list for total hip replacement . Ann R Coll Surg Engl . 2003 ; 85 ( 4 ): 269 – 271 . Crossref PubMed Google Scholar
13. Ackerman IN , Graves SE , Wicks IP , Bennell KL , Osborne RH . Severely compromised quality of life in women and those of lower socioeconomic status waiting for joint replacement surgery . Arthritis Rheum . 2005 ; 53 ( 5 ): 653 – 658 . Crossref PubMed Google Scholar
14. Desmeules F , Dionne CE , ÉL B , Bourbonnais R , Frémont P . The impacts of pre-surgery wait for total knee replacement on pain, function and health-related quality of life six months after surgery . J Eval Clin Pract . 2012 ; 18 ( 1 ): 111 – 120 . Crossref PubMed Google Scholar
15. Lingard EA , Katz JN , Wright EA , Sledge CB , Kinemax Outcomes Group . Predicting the outcome of total knee arthroplasty . J Bone Joint Surg Am . 2004 ; 86-A ( 10 ): 2179 – 2186 . Crossref PubMed Google Scholar
16. Ostendorf M , Buskens E , van Stel H , Schrijvers A , Marting L , Dhert W . Waiting for total hip arthroplasty: avoidable loss in quality time and preventable deterioration . J Arthroplasty . 2004 ; 19 ( 3 ): 302 – 309 . Crossref PubMed Google Scholar
17. Fortin PR , Penrod JR , Clarke AE , St-Pierre Y , Joseph L , Bélisle P . Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee . Arthritis Rheum . 2002 ; 46 ( 12 ): 3327 – 3330 . Google Scholar
18. Garbuz DS , Xu M , Duncan CP , Masri BA , Sobolev B . Delays worsen quality of life outcome of primary total hip arthroplasty . Clin Orthop . 2006 ; 447 : 79 – 84 . Crossref PubMed Google Scholar
19. Husted H , Holm G , Jacobsen S . Predictors of length of stay and patient satisfaction after hip and knee replacement surgery: fast-track experience in 712 patients . Acta Orthop . 2008 ; 79 ( 2 ): 168 – 173 . Crossref PubMed Google Scholar
20. Lin JJ , Kaplan RJ . Multivariate analysis of the factors affecting duration of acute inpatient rehabilitation after hip and knee arthroplasty . Am J Phys Med Rehabil . 2004 ; 83 ( 5 ): 344 – 352 . Crossref PubMed Google Scholar
21. Forrest G , Fuchs M , Gutierrez A , Girardy J . Factors affecting length of stay and need for rehabilitation after hip and knee arthroplasty . J Arthroplasty . 1998 ; 13 ( 2 ): 186 – 190 . Crossref PubMed Google Scholar
22. Forrest GP , Roque JM , Dawodu ST . Decreasing length of stay after total joint arthroplasty: effect on referrals to rehabilitation units . Arch Phys Med Rehabil . 1999 ; 80 ( 2 ): 192 – 194 . Crossref PubMed Google Scholar
23. Sloan M , Sheth NP . Length of stay and inpatient mortality trends in primary and revision total joint arthroplasty in the United States, 2000-2014 . J Orthop . 2018 ; 15 ( 2 ): 645 – 649 . Crossref PubMed Google Scholar
24. Burn E , Edwards CJ , Murray DW , Silman A , Cooper C , Arden NK . Trends and determinants of length of stay and hospital reimbursement following knee and hip replacement: evidence from linked primary care and NHS hospital records from 1997 to 2014 . BMJ Open . 2018 ; 8 ( 1 ): e019146 : e019146 . Crossref PubMed Google Scholar
25. Murphy BPD , Dowsey MM , Spelman T , Choong PFM . The impact of older age on patient outcomes following primary total knee arthroplasty . Bone Joint J . 2018 ; 100-B ( 11 ): 1463 – 1470 . Crossref PubMed Google Scholar
26. Rissanen P , Aro S , Paavolainen P . Hospital- and patient-related characteristics determining length of hospital stay for hip and knee replacements . Int J Technol Assess Health Care . 1996 ; 12 ( 2 ): 325 – 335 . Crossref PubMed Google Scholar
27. Spahn DR . Anemia and patient blood management in hip and knee surgery: a systematic review of the literature . Anesthesiology . 2010 ; 113 ( 2 ): 482 – 495 . Crossref PubMed Google Scholar
28. Meybohm P , Kohlhof H , Wirtz DC , Marzi I , Füllenbach C , Choorapoikayil S . Preoperative anaemia in primary hip and knee arthroplasty . Z Orthopadie Unfallchirurgie . Epub September 18 , 2019 . Crossref PubMed Google Scholar
29. Abdullah HR , Sim YE , Hao Y , Lin GY , Liew GHC , Lamoureux EL . Association between preoperative anaemia with length of hospital stay among patients undergoing primary total knee arthroplasty in Singapore: a single-centre retrospective study . BMJ Open . 2017 ; 7 ( 6 ): e016403 . Crossref PubMed Google Scholar
30. Inneh IA , Iorio R , Slover JD , Bosco JA . Role of sociodemographic, co-morbid and intraoperative factors in length of stay following primary total hip arthroplasty . J Arthroplasty . 2015 ; 30 ( 12 ): 2092 – 2097 . Crossref PubMed Google Scholar
31. Olthof M , Stevens M , Bulstra SK , Akker-Scheek van den . The association between comorbidity and length of hospital stay and costs in total hip arthroplasty patients: a systematic review . J Arthroplasty . 2014 ; 29 ( 5 ): 1009 – 1014 . Crossref PubMed Google Scholar
32. Halawi MJ , Vovos TJ , Green CL , Wellman SS , Attarian DE , Bolognesi MP . Preoperative predictors of extended hospital length of stay following total knee arthroplasty . J Arthroplasty . 2015 ; 30 ( 3 ): 361 – 364 . Crossref PubMed Google Scholar
33. Kreder HJ , Grosso P , Williams JI , Jaglal S , Axcell T , Wal EK . Provider volume and other predictors of outcome after total knee arthroplasty: a population study in Ontario . Can J Surg J Can Chir . 2003 ; 46 ( 1 ): 15 – 22 . PubMed Google Scholar
34. Tay KS , Cher EWL , Zhang K , Tan SB , Howe TS , JSB K . Comorbidities have a greater impact than age alone in the outcomes of octogenarian total knee arthroplasty . J Arthroplasty . 2017 ; 32 ( 11 ): 3373 – 3378 . Crossref PubMed Google Scholar
35. Pugely AJ , Martin CT , Gao Y , Belatti DA , Callaghan JJ . Comorbidities in patients undergoing total knee arthroplasty: do they influence hospital costs and length of stay . Clin Orthop . 2014 ; 472 ( 12 ): 3943 – 3950 . Crossref PubMed Google Scholar
36. Hart A , Bergeron SG , Epure L , Huk O , Zukor D , Antoniou J . Comparison of US and canadian perioperative outcomes and hospital efficiency after total hip and knee arthroplasty . JAMA Surg . 2015 ; 150 ( 10 ): 990 – 998 . Crossref PubMed Google Scholar
37. Papachristofi O , Klein AA , Mackay J , Nashef S , Fletcher N , Sharples LD . Effect of individual patient risk, centre, surgeon and anaesthetist on length of stay in hospital after cardiac surgery: Association of Cardiothoracic Anaesthesia and Critical Care (ACTACC) consecutive cases series study of 10 UK specialist centres . BMJ Open . 2017 ; 7 ( 9 ): e016947 : e016947 . Crossref PubMed Google Scholar
38. Krell RW , Girotti ME , Dimick JB . Extended length of stay after surgery: complications, inefficient practice, or sick patients? JAMA Surg . 2014 ; 149 ( 8 ): 815 – 820 . Google Scholar
39. Husted H , Jensen CM , Solgaard S , Kehlet H . Reduced length of stay following hip and knee arthroplasty in Denmark 2000-2009: from research to implementation . Arch Orthop Trauma Surg . 2012 ; 132 ( 1 ): 101 – 104 . Crossref PubMed Google Scholar
40. Cummings JJ , Ehrenfeld JM , McEvoy MD . A Guide to Implementing Enhanced Recovery After Surgery Protocols: Creating, Scaling, and Managing a Perioperative Consult Service . Int Anesthesiol Clin . 2017 ; 55 ( 4 ): 101 – 115 . Crossref PubMed Google Scholar
41. Gani F , Johnston FM , Nelson-Williams H , Cerullo M , Dillhoff ME , Schmidt CR . Hospital Volume and the Costs Associated with Surgery for Pancreatic Cancer . J Gastrointest Surg Off J Soc Surg Aliment Tract . 2017 ; 21 ( 9 ): 1411 – 1419 . Crossref PubMed Google Scholar
42. Neuman MD , Rosenbaum PR , Ludwig JM , Zubizarreta JR , Silber JH . Anesthesia technique, mortality, and length of stay after hip fracture surgery . JAMA . 2014 ; 311 ( 24 ): 2508 – 2517 . Crossref PubMed Google Scholar
43. Yoon RS , Nellans KW , Geller JA , Kim AD , Jacobs MR , Macaulay W . Patient education before hip or knee arthroplasty lowers length of stay . J Arthroplasty . 2010 ; 25 ( 4 ): 547 – 551 . Google Scholar
44. Vorhies JS , Wang Y , Herndon J , Maloney WJ , Huddleston JI . Readmission and length of stay after total hip arthroplasty in a national Medicare sample . J Arthroplasty . 2011 ; 26 ( 6 Suppl ): 119 – 123 . Crossref PubMed Google Scholar
45. Hayes JH , Cleary R , Gillespie WJ , Pinder IM , Sher JL . Are clinical and patient assessed outcomes affected by reducing length of hospital stay for total hip arthroplasty . J Arthroplasty . 2000 ; 15 ( 4 ): 448 – 452 . Crossref PubMed Google Scholar
46. Seangleulur A , Vanasbodeekul P , Prapaitrakool S , Worathongchai S , Anothaisintawee T , McEvoy M . The efficacy of local infiltration analgesia in the early postoperative period after total knee arthroplasty: A systematic review and meta-analysis . Eur J Anaesthesiol . 2016 ; 33 ( 11 ): 816 – 831 . Crossref PubMed Google Scholar
47. Saklad M . Grading of patients for surgical procedures . Anesthesiol . 1941 ; 2 ( 5 ): 281 – 284 . Google Scholar
Author contributions
S. Seddigh: Investigation, Formal analysis, Writing - original draft.
L. Lethbridge: Investigation, Formal analysis.
P. Theriault: Investigation, Formal analysis, Writing - editing & reviewing.
S. Matwin: Writing - editing & reviewing.
M. J. Dunbar: Writing - editing & reviewing, Supervision.
Funding statement
The author or one or more of the authors have received or will receive benefits for personal or professional use from a commercial party related directly or indirectly to the subject of this article.
ICMJE COI statement
M. J. Dunbar declares personal payments for consultancy and royalties from Stryker, unrelated to this study.
Open access funding
The open access funding for this study was self-funded.
Acknowledgements
The authors would like to thanks Joanne Douglas for her contributions in research task management and mediating collaboration between authors.
Ethical review statement
REB FILE #: 1023254 This study has been reviewed and granted approval by an assigned Co-Chair and on behalf of the Nova Scotia Health Research Ethics Board.
© 2021 Author(s) et al. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND 4.0) licence, which permits the copying and redistribution of the work only, and provided the original author and source are credited. See https://creativecommons.org/licenses/by-nc-nd/4.0/